CGEN
Price
$1.66
Change
-$0.03 (-1.78%)
Updated
Jun 27 closing price
Capitalization
156.55M
32 days until earnings call
RLAY
Price
$3.30
Change
-$0.02 (-0.60%)
Updated
Jun 27 closing price
Capitalization
565.77M
43 days until earnings call
Interact to see
Advertisement

CGEN vs RLAY

Header iconCGEN vs RLAY Comparison
Open Charts CGEN vs RLAYBanner chart's image
Compugen
Price$1.66
Change-$0.03 (-1.78%)
Volume$111.5K
Capitalization156.55M
Relay Therapeutics
Price$3.30
Change-$0.02 (-0.60%)
Volume$2.08M
Capitalization565.77M
CGEN vs RLAY Comparison Chart in %
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEN vs. RLAY commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Buy and RLAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CGEN: $1.66 vs. RLAY: $3.30)
Brand notoriety: CGEN and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 52% vs. RLAY: 109%
Market capitalization -- CGEN: $155M vs. RLAY: $565.77M
CGEN [@Biotechnology] is valued at $155M. RLAY’s [@Biotechnology] market capitalization is $565.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEN is a better buy in the long-term than RLAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 3 bullish TA indicator(s).

  • CGEN’s TA Score: 5 bullish, 4 bearish.
  • RLAY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CGEN is a better buy in the short-term than RLAY.

Price Growth

CGEN (@Biotechnology) experienced а +1.22% price change this week, while RLAY (@Biotechnology) price change was +3.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CGEN is expected to report earnings on Jul 31, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($566M) has a higher market cap than CGEN($157M). CGEN YTD gains are higher at: 8.497 vs. RLAY (-19.903). CGEN has higher annual earnings (EBITDA): -14.79M vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. CGEN (104M). CGEN has less debt than RLAY: CGEN (2.77M) vs RLAY (47.2M). CGEN has higher revenues than RLAY: CGEN (27.6M) vs RLAY (7.68M).
CGENRLAYCGEN / RLAY
Capitalization157M566M28%
EBITDA-14.79M-373.07M4%
Gain YTD8.497-19.903-43%
P/E Ratio60.33N/A-
Revenue27.6M7.68M359%
Total Cash104M710M15%
Total Debt2.77M47.2M6%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENRLAY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSECX33.750.16
+0.48%
Calvert Equity C
FGIPX15.840.06
+0.38%
Macquarie Growth and Income Instl
BSGIX16.040.03
+0.19%
Baird Small/Mid Cap Growth Institutional
VKSFX10.29N/A
N/A
Virtus KAR Small-Mid Cap Value I
GRHAX15.03-0.23
-1.51%
Goehring & Rozencwajg Resources Retail

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with BDTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
-1.78%
BDTX - CGEN
46%
Loosely correlated
-4.07%
ROIV - CGEN
42%
Loosely correlated
-1.81%
ARWR - CGEN
40%
Loosely correlated
+0.06%
BBIO - CGEN
40%
Loosely correlated
-0.59%
RLAY - CGEN
39%
Loosely correlated
-0.60%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-0.60%
XNCR - RLAY
52%
Loosely correlated
-3.10%
BCYC - RLAY
50%
Loosely correlated
-0.55%
IMNM - RLAY
49%
Loosely correlated
-0.23%
BDTX - RLAY
47%
Loosely correlated
-4.07%
RXRX - RLAY
46%
Loosely correlated
-6.85%
More